111 Inc (YI)
1.18
-0.05
(-4.06%)
USD |
NASDAQ |
May 31, 16:00
1.19
+0.01
(+0.85%)
After-Hours: 20:00
111 Shares Outstanding: 85.66M for March 31, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
| Date | Value |
|---|---|
| March 31, 2024 | 85.66M |
| December 31, 2023 | 85.52M |
| March 31, 2023 | 83.99M |
| December 31, 2022 | 83.52M |
| March 31, 2022 | 83.27M |
| December 31, 2021 | 83.07M |
| March 31, 2021 | 82.87M |
| December 31, 2020 | 82.68M |
| March 31, 2020 | 82.36M |
| Date | Value |
|---|---|
| December 31, 2019 | 82.06M |
| September 30, 2019 | 82.45M |
| June 30, 2019 | 81.66M |
| March 31, 2019 | 81.66M |
| December 31, 2018 | 81.54M |
| September 30, 2018 | 81.54M |
| September 12, 2018 | 80.73M |
| September 07, 2018 | 82.86M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
81.66M
Minimum
Jun 30 2019
85.66M
Maximum
Mar 31 2024
83.26M
Average
82.97M
Median
Shares Outstanding Benchmarks
| Concord Medical Services Holdings Ltd | 43.42M |
| Sinovac Biotech Ltd | 99.64M |
| CASI Pharmaceuticals Inc | 13.40M |
| Zai Lab Ltd | 98.72M |
| Gracell Biotechnologies Inc (DELISTED) | 95.93M |